Your browser doesn't support javascript.
loading
Meta-analysis of clinical outcomes of PCSK9 modulators in patients with established ASCVD.
Talasaz, Azita H; Ho, Ai-Chen Jane; Bhatty, Fawzia; Koenig, Rachel A; Dixon, Dave L; Baker, William L; Van Tassell, Benjamin W.
Afiliação
  • Talasaz AH; Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, USA.
  • Ho AJ; Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, USA.
  • Bhatty F; Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, USA.
  • Koenig RA; Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, USA.
  • Dixon DL; Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, USA.
  • Baker WL; Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, Connecticut, USA.
  • Van Tassell BW; Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, Virginia, USA.
Pharmacotherapy ; 41(12): 1009-1023, 2021 12.
Article em En | MEDLINE | ID: mdl-34657313

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Aterosclerose / Pró-Proteína Convertase 9 Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Aterosclerose / Pró-Proteína Convertase 9 Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article